<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335733">
  <stage>Registered</stage>
  <submitdate>21/07/2010</submitdate>
  <approvaldate>23/07/2010</approvaldate>
  <actrnumber>ACTRN12610000595011</actrnumber>
  <trial_identification>
    <studytitle>Physical activity levels of patients with cystic fibrosis  admitted to hospital with an acute pulmonary exacerbation</studytitle>
    <scientifictitle>The effect of hospitalisation with an acute pulmonary exacerbation on the physical activity levels, exercise tolerance and grip strength of patients with cystic fibrosis</scientifictitle>
    <utrn>nil</utrn>
    <trialacronym />
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>cystic fibrosis</healthcondition>
    <conditioncode>
      <conditioncode1>Human genetics and inherited disorders</conditioncode1>
      <conditioncode2>Cystic fibrosis</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Other respiratory disorders / diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Physical activity levels will be measured, using a SenseWear Pro 3 Armband, for a 24 hour period between days 3 and 5 of the hospitalisation period and 1 month after discharge. A clinical exercise test, the modified shuttle walk test, will be undertaken on day 5/6 of hospitalisation and 1 month after discharge from hospital to assess exercise tolerance. The exercise tests will be undertaken at (slightly) different time points to the assessment of physical activity levels to avoid the exercise tests affecting the measurement of physical activity levels. Skeletal muscle grip strength will be measured between days 3 and 5 of the hospitalisation period and 1 month after discharge using a calibrated Jamar dynamometer. The study will continue until the required sample size (n = 34) is achieved.</interventions>
    <comparator>Uncontrolled</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Physical activity levels will be measured for a 24 hour period using the SenseWear Pro 3 Armband.</outcome>
      <timepoint>Between days 3 and 5 of hospitalisation and 1 month after discharge from hospital.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Exercise performance levels will be assessed using a performance-based test, namely, the modified shuttle walk test</outcome>
      <timepoint>Between days 3 and 5 of hospitalisation and 1 month after discharge from hospital.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Grip strength will be assessed using a calibrated Jamar dynamometer on setting 2</outcome>
      <timepoint>Between days 3 and 5 of hospitalisation and 1 month after discharge from hospital.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Adult patients with cystic fibrosis admitted to the Royal Adelaide Hospital with an acute exacerbation of their pulmonary disease.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Patients will be excluded if they are unwilling to participate or unable to commit to the 1 month follow-up measurements.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/09/2010</anticipatedstartdate>
    <actualstartdate>26/10/2010</actualstartdate>
    <anticipatedenddate />
    <actualenddate>25/10/2011</actualenddate>
    <samplesize>34</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Nathan Ward</primarysponsorname>
    <primarysponsoraddress>Physiotherapy Department, Royal Adelaide Hospital, North Terrace, Adelaide, SA 5000.</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Royal Adelaide Hospital Allied Health Research Grant</fundingname>
      <fundingaddress>Jacqui Beaty
Allied Health Research Grant Committee
Speech Pathology Dept
Level 5, Allied Health Building
Royal Adelaide Hospital
North Terrace
Adelaide 
SA 5000</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dianne White</sponsorname>
      <sponsoraddress>Physiotherapy Department, Royal Adelaide Hospital, North Terrace, Adelaide, SA 5000.</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Hilary Rowe</sponsorname>
      <sponsoraddress>Physiotherapy Department, Royal Adelaide Hospital, North Terrace, Adelaide, SA 5000.</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Kathy Stiller</sponsorname>
      <sponsoraddress>Physiotherapy Department, Royal Adelaide Hospital, North Terrace, Adelaide, SA 5000.</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Thomas Sullivan</sponsorname>
      <sponsoraddress>Data Management and Analysis Centre, Discipline of Public Health, University of Adelaide, Adelaide, SA 5005.</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>To determine objectively how inactive cystic fibrosis patients are during and after a hospital admission for an acute pulmonary exacerbation by assessing them using a highly accurate physical activity level monitor. The study also seeks to determine whether exercise tolerance and skeletal muscle strength are reduced during periods of hospitalisation for an acute exacerbation.</summary>
    <trialwebsite />
    <publication>Ward N, White D, Rowe H, Stiller K, Sullivan T (2013)
Physical activity levels of patients with cystic fibrosis hospitalised with an acute respiratory exacerbation. Respiratory Medicine 107:1014-1020.

Ward N, White D, Rowe H, Stiller K (2011)
Physical activity levels of adult patients with cystic fibrosis during hospitalisation for an acute respiratory exacerbation. 9th Australasian Cystic Fibrosis Conference, 2011, Melbourne, Australia.
</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Adelaide Hospital Research Ethics Committee</ethicname>
      <ethicaddress>Research Ethics Committee, Level 3, Hanson Institute,
Royal Adelaide Hospital, North Terrace, Adelaide, SA 5000.</ethicaddress>
      <ethicapprovaldate>20/07/2010</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Kathy Stiller</name>
      <address>Physiotherapy Department, Royal Adelaide Hospital, North Terrace, Adelaide, SA 5000.</address>
      <phone>+61 8 82225334</phone>
      <fax />
      <email>kathy.stiller@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Kathy Stiller</name>
      <address>Physiotherapy Department, Royal Adelaide Hospital, North Terrace, Adelaide, SA 5000.</address>
      <phone>+61 8 82225334</phone>
      <fax />
      <email>kathy.stiller@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Nathan Ward</name>
      <address>Physiotherapy Department, Royal Adelaide Hospital, North Terrace, Adelaide, SA 5000</address>
      <phone>61 8 82225334</phone>
      <fax>61 8 82224279</fax>
      <email>nathan.ward@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>